Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,083 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Harrow Eye, LLC | $317.09 | 2 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $271.94 | 13 | $0 (2024) |
| Horizon Therapeutics plc | $112.73 | 1 | $0 (2022) |
| Oyster Point Pharma, Inc. | $102.85 | 4 | $0 (2024) |
| Tarsus Pharmaceuticals, Inc. | $97.24 | 4 | $0 (2024) |
| ABBVIE INC. | $51.55 | 2 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $29.51 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $28.31 | 1 | $0 (2023) |
| Alcon Vision LLC | $21.95 | 1 | $0 (2022) |
| BioTissue Holdings, Inc. | $18.67 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $745.09 | 20 | Harrow Eye, LLC ($317.09) |
| 2023 | $116.20 | 5 | Bausch & Lomb Americas Inc. ($58.33) |
| 2022 | $190.55 | 5 | Horizon Therapeutics plc ($112.73) |
| 2021 | $14.70 | 1 | Allergan, Inc. ($14.70) |
| 2019 | $16.35 | 1 | Eyevance Pharmaceuticals LLC ($16.35) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Ophthalmology | ||||||
| 11/27/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: EYE CARE | ||||||
| 08/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Ophthalmology | ||||||
| 07/29/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: EYE CARE | ||||||
| 07/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/16/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Ophthalmology | ||||||
| 06/26/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Ophthalmology | ||||||
| 05/23/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $36.09 | General |
| Category: Dry eyes | ||||||
| 04/16/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Ophthalmology | ||||||
| 04/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Ophthalmology | ||||||
| 04/09/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Ophthalmology | ||||||
| 03/29/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/28/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $185.55 | General |
| 02/28/2024 | Harrow Eye, LLC | — | Food and Beverage | In-kind items and services | $131.54 | General |
| 02/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: Ophthalmology | ||||||
| 02/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/02/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Ophthalmology | ||||||
| 11/27/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Ophthalmology | ||||||
| 09/22/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Ophthalmology | ||||||
| 08/29/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Ophthalmology | ||||||
| 05/08/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Ophthalmology | ||||||
| 03/14/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: DRY EYE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 850 | 974 | $245,028 | $57,160 |
| 2022 | 8 | 658 | 762 | $206,986 | $46,712 |
| 2021 | 8 | 543 | 598 | $181,724 | $41,744 |
| 2020 | 8 | 361 | 384 | $87,844 | $24,235 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 248 | 259 | $74,333 | $19,253 | 25.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 175 | 175 | $60,725 | $15,654 | 25.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 104 | 155 | $30,690 | $8,326 | 27.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 71 | 96 | $12,672 | $3,840 | 30.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 85 | 105 | $9,240 | $2,333 | 25.3% |
| 92134 | Imaging of retina | Office | 2023 | 65 | 74 | $7,030 | $2,006 | 28.5% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 18 | 26 | $38,948 | $2,004 | 5.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,187 | $1,995 | 38.5% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 20 | 20 | $3,760 | $1,028 | 27.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 31 | 31 | $1,953 | $619.30 | 31.7% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 14 | 14 | $490.00 | $101.36 | 20.7% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 212 | 220 | $63,140 | $17,024 | 27.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 138 | 138 | $47,886 | $12,505 | 26.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 103 | 149 | $29,502 | $8,233 | 27.9% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 54 | 70 | $9,240 | $2,833 | 30.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2022 | 23 | 29 | $43,442 | $2,217 | 5.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 59 | 76 | $6,688 | $1,826 | 27.3% |
| 92134 | Imaging of retina | Office | 2022 | 53 | 64 | $6,080 | $1,767 | 29.1% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 16 | 16 | $1,008 | $306.90 | 30.4% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 159 | 159 | $55,173 | $15,402 | 27.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 148 | 154 | $44,198 | $12,256 | 27.7% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 78 | 110 | $21,780 | $6,506 | 29.9% |
| 66984 | Removal of cataract with insertion of lens, simple | Office | 2021 | 21 | 28 | $41,944 | $2,223 | 5.3% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 39 | 39 | $7,332 | $1,879 | 25.6% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 30 | 36 | $4,702 | $1,590 | 33.8% |
About Brooke Houser
Brooke Houser is a Optometrist healthcare provider based in Fort Smith, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2018. The National Provider Identifier (NPI) number assigned to this provider is 1780188193.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brooke Houser has received a total of $1,083 in payments from pharmaceutical and medical device companies, with $745.09 received in 2024. These payments were reported across 32 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,083).
As a Medicare-enrolled provider, Houser has provided services to 2,412 Medicare beneficiaries, totaling 2,718 services with total Medicare billing of $169,852. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Other Specialties Optometrist, Optometrist
- Location Fort Smith, AR
- Active Since 03/20/2018
- Last Updated 12/02/2025
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1780188193
Products in Payments
- MIEBO (Drug) $199.28
- TEPEZZA (Drug) $112.73
- TYRVAYA (Drug) $102.85
- XDEMVY (Drug) $97.24
- VYZULTA (Drug) $72.66
- LUMIGAN (Drug) $66.25
- Cequa (Drug) $29.51
- XIIDRA (Drug) $28.31
- rhopressa (Drug) $21.95
- PROKERA (Device) $18.67
- Flarex (Drug) $16.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Fort Smith
Dr. Malcolm Hutchins, O.d, O.D
Optometrist — Payments: $3,122
Dr. Matthew Renner, Od, OD
Optometrist — Payments: $2,958
Dr. Shane Laster, O.d, O.D
Optometrist — Payments: $2,871
Dr. Steven Stiles, O.d, O.D
Optometrist — Payments: $1,797
Jessica Larson, Od, OD
Optometrist — Payments: $1,466
Dr. Seth Laster, Od, OD
Optometrist — Payments: $1,396